17-KETOSTEROID EXCRETION, MYASTHENIA, AND CANCER
- 8 April 1972
- journal article
- Published by Elsevier in The Lancet
- Vol. 299 (7754) , 790
- https://doi.org/10.1016/s0140-6736(72)90539-9
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Addison's disease, vitiligo and multiple autoantibodiesPublished by Oxford University Press (OUP) ,1972
- Decreased Conversion of Androgens to Normal 17-Ketosteroid Metabolites: A Nonspecific Consequence of IllnessJournal of Clinical Endocrinology & Metabolism, 1971
- A method for deriving normal ranges from laboratory specimens applied to uric acid in malesJournal of Clinical Pathology, 1970
- SARCOIDOSIS, THYROIDITIS, AND ADDISON'S DISEASEThe Lancet, 1970
- Immunological disturbances in myasthenia gravis with a report of Hashimoto's disease developing after thymectomyJournal of Neurology, Neurosurgery & Psychiatry, 1964
- The Clinical Value of Urinary 17-Ketogenic Steroid DeterminationsJournal of Clinical Pathology, 1957